干细胞R﹠D  
基础研究 您当前的位置:首页>干细胞R﹠D>基础研究
科技动态
 
荣誉成就
日期:2013-11-18  浏览次数:444

刘兵

 307-青藤转化医学中心主任、307-青藤免疫健康中心主任

发表论文
第一和通讯作者论文:9篇
1.Liu Y, Liu Q, Wang T, Bian L, Zhang SH, Hu HX, Li S, Hu ZY, Wu SK, Liu B*, Jiang Z*. Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker. BMC Cancer, 2013. * 通讯作者

2. Li Z, Lan Y, He WY, Chen DB, Wang J, Zhou F, Wang Y, Sun HY, Chen XD, Xu CH, Li S, Pang YK, Zhu LL, Fan M, Shang AJ, Ju ZY, Luo LF, Ding YQ, Guo W, Yuan WP, Yang X,* and Liu B* Mouse Embryonic Head as a Site for Hematopoietic Stem Cell Development. Cell Stem Cell. 2012, 11(5): 663-675. * 通讯作者

3. Liu GX*, Yang WW, Guo M, Liu XQ, Huang NX, Li DF, Jiang ZF, Yang WF, Zhang WJ, Su H, Liu ZQ, Liu TQ, Wang DM, Huang S, Yao B, Man QH, Qiu LJ, Sun XD, Sun YY, Liu B*. Effective Modulation of CD4+CD25+high Regulatory T and NK Cells in Malignant Patients by Combination of Interferon-ɑ and Interleukin-2. Cancer Immunology & Immunotherapy. 2012, 61(12):2357-66. * 通讯作者

4. Zhou JN, Chen HX, Li ST, Xie YF, He WY, Nan X, Yue W, Liu B*, Pei XT*. Fibroblastic Potential of CD41+ Cells in the Mouse AGM Region and Yolk Sac. Stem Cells & Development. 2012, 21(14):2592-605. * 通讯作者

5. Yan XL, Lan Y, Wang XY, He WY, Yao HY, Chen DB, Xiong JX, Gao J, Li Z, Yang G, Li XS, Liu YL, Zhang JY, Liu B*, Mao N*. Migration of Dorsal Aorta Mesenchymal Stem Cells Induced by Mouse Embryonic Circulation. Developmental Dynamics. 2011, 240: 65-74. * 通讯作者

6. He WY, Lan Y, Yao HY, Li Z, Wang XY, Li XS, Zhang JY, Zhang Y, Liu B*, Mao N*. Interleukin-3 Promotes Hemangioblast Development in Mouse Aorta-gonad-mesonephros Region. Haematologica. 2010,95(6):875-883. * 通讯作者

7. Wang XY, Lan Y, He WY, Zhang L, Yao HY, Hou CM, Tong Y, Liu YL, Yang G, Liu XD, Yang X, Liu B*, Mao N*. Identification of Mesenchymal Stem Cells in Aorta-gonad-mesonephros and Yolk Sac of Human Embryos. Blood. 2008, 111(4): 2436-2443. * 通讯作者

8. Yao H #Liu B #, Wang X, Lan Y, Hou N, Yang X, Mao N. Identification of High Proliferative Potential Precursors with Hemangioblastic Activity in the Mouse AGM Region. Stem Cells. 2007, 25(6):1423-30. # 共同第一作者

9. Liu B #, Sun YX #, Jiang FZ, Zhang SX, Wu Y, Lan Y, Yang X, Mao N. Disruption of Smad5 gene leads to enhanced proliferation of high-proliferative potential precursors during embryonic hematopoiesis. Blood, 2003; 101: 124-133。 # 共同第一作者

 

刘广贤

 307-青藤转化医学中心副主任、307-青藤免疫健康中心副主任

发表论文
近五年发表论文
1.Guangxian Liu*, Wuwei Yang,Mei Guo, Xiaoqing Liu, Naixiang Huang, Dingfeng Li,Zefei Jiang,Wenfeng Yang, Weijing Zhang , Hang Su, Zhiqing Liu, Tieqiang Liu, DongmeiWang, Shan Huang ,Bo Yao, Qiuhong Man, Lijuan Qiu, Xuedong Sun, Yuying Sun, BingLiu*. Effective modulation of CD4+CD25high regulatory T and NK cells in malignant patientsby combination of interferon-a and interleukin-2. Cancer Immunol Immunother  2012,61:2357–2366

2.王宏 刘广贤 卓海龙 白文林 吴煜 周霖 楼敏 曾珍 常秀娟 徐建明。携带hIFN-γ的内皮祖细胞增强肿瘤化疗后维持治疗的效果。中国肿瘤生物治疗杂志,第17卷,第5期,第521-524页,2010年(共同通信作者)

3.张雁敏,邱泽武*,刘广贤*。骨髓间充质干细胞治疗大鼠百草枯中毒急性肺损伤的作用。中华急诊医学杂志,第20卷,第1期, 39-43页, 2011年 (共同通信作者)

4.刘佳,王全立*,刘广贤*, 孙雪冬, 谭燕。自然杀伤细胞免疫球蛋白样受体基因与白血病的关联性研究。第三军医大学学报,第30卷, 第9期, 794-796页, 2009年(共同通信作者)

5.Yao B, Li Y, Liu G, Guo M, Bai J, Man Q, Qiu L, Ai H. Estimation of the biological dose received by five victims of a radiation accident using three different cytogenetic tools. Mutat Res. 2013; 751(1):66-72

6.Wei L, Zuo H, Sun X, Liu T, Guo M, Liu G, Sun Q, Qiao J, Wang D, Yu C, Hu K, Dong Z, Ai H. WT1-specific CTL cells of recipient origin may exist in the peripheral blood of patients achieving full donor chimerism soon after nonmyeloablative transplantation. Clin Transplant. 2011; 25(5):689-96

7.Mei Guo, Kai-Xun Hu, Chang-Lin Yu, Qi-Yun Sun, Jian-Hui Qiao, Dan-Hong Wang, Guang-XianLiu, Wan-Jun Sun, Li Wei, Xue-Dong Sun, Ya-Jiang Huang, Jun-Xiao Qiao, Zheng Dong, and Hui-Sheng Ai*. Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients. Blood  2011, 117(3):936-941

8.Mei Guo, Kai-Xun Hu, Guang-Xian Liu, Chang-Lin Yu, Jian-Hui Qiao, Qi-Yun Sun, Jun-Xiao Qiao,Zheng Dong, Wan-Jun Sun, Xue-Dong Sun, Hong-Li Zuo, Qiu-Hong Man, Zhi-Qing Liu, Tie-Qiang Liu,Hong-Xia Zhao, Ya-Jing Huang, Li Wei, Bing Liu, Juan Wang, Xu-Liang Shen, and Hui-Sheng Ai*. HLA-Mismatched Stem-Cell Microtransplantation As Postremission Therapy for Acute Myeloid Leukemia: Long-Term Follow-Up. JCO, 2012 doi: 10.1200/JCO.2012.45.2979

9.Wei Li*, Zuo Hongli,Sun Xuedong,Liu Tieqang, Guo Mei, Liu Guangxian, Sun Qiyun, Qiao Jianhui, Wang Danhong, Yu Changlin, Hu Kaixun, Dong Zheng, Ai Huisheng*. Comparison of Wilms’ Tumor antigen 1-specific Tlymphocyte generation soon after nonmyeloablative allergenic stem-cell transplantation in acute and chronic leukemia patients. Int J Hematol 2010, 91:652-660


刘毅

发表论文
第一和通讯作者论文:6篇

1. Yi Liu*†, Bing Liu†, Xiao-Yan Li, Jian-Jie Li, Hai-Feng Qin, Chuan-Hao Tang, Wan-Feng Guo, Hai-Xu Hu, Sha Li, Cui-Jing Chen, Bing Liu, Hong-Jun Gao and Xiao-Qing Liu*: A comparison of ARMS and direct sequencing for EGFR mutation analysis and Tyrosine Kinase Inhibitors treatment prediction in body fluid samples of Non-Small-Cell Lung Cancer patients. Journal of Experimental & Clinical Cancer Research 30:111. 2011   †:共同第一作者  *:共同通讯作者

2. 刘毅,刘兵,江泽飞 从HER-2 检测研究进展谈转化医学在乳腺癌诊治中的重要作用 中国实用外科杂志 32(1):41-44,2012

3. Yi Liu†, Qian Liu†, Tao Wang, Li Bian, Shaohua Zhang, Haixu Hu, Sha Li, Zhiyuan Hu, Shikai Wu,Bing Liu* and Zefei Jiang*: Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker. BMC Cancer 2013, 13:202  †:共同第一作者

4. Tang C†, Liu Y*†, Qin H, Li X, Guo W, Li J, Wang W, Qu L, Hu H, Xu C, Zheng L, Huang Y, Liu B, Gao H, Halleen JM, Liu X*. Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients. Clin Chim Acta 2013, 426: 102-107  †:共同第一作者  *:共同通讯作者

5. 李莎,张丽娟,胡海旭,徐春红,刘毅*: 表皮生长因子受体基因突变检测方法概述. 《中华病理学杂志》 42(7):495-497, 2013  *:通讯作者

参编专著:2部
1.刘毅 《分子病理学:疾病的分子基础》,第七章:转录组在理解人类疾病中的意义(译著)P150-183,科学出版社,120万字,2012年3月第1版第1次印刷

2.刘毅 《现代乳腺癌全程管理:新理念和临床策略》,第一章第五节:分子标记物 P49-62,上海科学技术出版社,2013年4月第1版第1次印刷


上一篇:没有了!
下一篇:研究方向
OEM:201107272203261305